Dynamic Computed Tomography Perfusion Imaging: Complementary Diagnostic Tool in Hepatocellular Carcinoma Assessment From Diagnosis to Treatment Follow-up

• Published in: Academic radiology Vol. 26; no. 12; pp. 1675 - 1685
• Main Authors: Ippolito, Davide, Pecorelli, Anna, Querques, Giulia, Drago, Silvia Girolama, Maino, Cesare, Franzesi, Cammillo Talei, Hatzidakis, Adam, Sironi, Sandro
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-12-2019
• Subjects: Computed tomography; Hepatocellular carcinoma; Perfusion imaging; Radiofrequency ablation; Sorafenib; Transarterial chemoembolization; Radiofrequency ablation; Hepatocellular carcinoma; Computed tomography; Perfusion imaging; Transarterial chemoembolization; Sorafenib
• ISSN: 1076-6332; 1878-4046
• DOI: 10.1016/j.acra.2019.02.010

Early diagnosis of HCC is of paramount importance in order to enable the application of curative treatments. Among these, radiofrequency ablation (RFA) is actually considered the most effective ablative therapy for early stage hepatocellular carcinoma (HCC) not suitable for surgery. On the other hand, transarterial chemoembolization (TACE) represents the standard of care for intermediate stage HCC and compensated liver function. Finally, sorafenib, an oral antiangiogenic targeted drug, is the only approved systemic therapy for advanced HCC with vascular invasion, extrahepatic spread, and well-preserved liver function. Beside traditional radiological techniques, new functional imaging tools have been introduced in order to provide not only morphological information but also quantitative functional data. In this review, we analyze perfusion-CT (pCT) from a technical point of view, describing the main different mathematical analytical models for the quantification of tissue perfusion from acquired CT raw data, the most commonly acquired perfusion parameters, and the technical parameters required to perform a standard pCT examination. Moreover, a systematic review of the literature was performed to assess the role of pCT as an emerging imaging biomarker for HCC diagnosis, response evaluation to RFA, TACE, and sorafenib, and we examine its challenges in HCC management.